Use of an extracorporeal glucose monitor for the diagnosis and surgical treatment of an insulinoma.

Buysschaert, Martin;Lambotte, Luc;Reynaert, M.;Kestens, Paul;Lambert, A E;et.al.
(1980) British Journal of Surgery — Vol. 67, n° 12, p. 841-844 (1980)

Files

No attached file found for this publication.

Details

Authors
  • Buysschaert, MartinUCLouvain
    Author
  • Lambotte, LucUCLouvain
    Author
  • Reynaert, M.UCLouvain
    Author
  • Kestens, PaulUCLouvain
    Author
  • Ketelslegers, Jean-MarieUCLouvain
    Author
  • Lambert, A E
    Author
Show more
Abstract
An extracorporeal glucose monitor (EGM) has been used in a patient with an insulinoma. This system, which continuously measures blood glucose, can be used in combination with a feedback-controlled glucose infusion to maintain glycaemia at any preselected level. It prevents the risk of severe hypoglycaemia during diagnostic tests (total fast, tolbutamide and insulin tolerance tests) as well as during surgery. It also helps in determining whether all the insulin-secreting tumour tissue has been removed. The EGM is thus helpful in the diagnosis and surgical treatment of insulinomas.
Affiliations

Citations

Buysschaert, M., Lambotte, L., Reynaert, M., Kestens, P., Ketelslegers, J.-M., & Lambert, A. E. (1980). Use of an extracorporeal glucose monitor for the diagnosis and surgical treatment of an insulinoma. British Journal of Surgery, 67(12), 841-844. https://hdl.handle.net/2078.5/50262 (Original work published 1980)